Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Virus Res ; 170(1-2): 66-74, 2012 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-23000117

RESUMO

Enterovirus is the most common pathogen causing viral meningitis especially in children. Besides the blood-brain barrier (BBB) the choroid plexus, which forms the blood-cerebrospinal-fluid (CSF) barrier (BCSFB), was shown to be involved in the pathogenesis of enteroviral meningitis. In a human in vitro model of the BCSFB consisting of human choroid plexus papilloma cells (HIBCPP), the permissiveness of plexus epithelial cells for Echovirus 30 (EV30) was analyzed by immunoblotting and quantitative real-time PCR (Q-PCR). HIBCPP could be directly infected by EV30 from the apical as well as from the physiological relevant basolateral side. During an infection period of 5h no alterations of barrier function and cell viability could be observed. Analysis of the cytokine/chemokine-profile following enteroviral infection with a cytometric bead array (CBA) and Q-PCR revealed an enhanced secretion of PanGRO (CXCL1, CXCL2 and CXCL3), IL8 and CCL5. Q-PCR showed a significant upregulation of CXCL1, CXCL2 and CXCL3 in a time dependant manner. However, there was only a minor effect of HIBCPP-infection with EV30 on transepithelial T lymphocyte migration with or without the chemoattractant CXCL12. Moreover, CXCL3 did not significantly enhance T cell migrations. Therefore additional factors must be involved for the in vivo reported enhanced T cell migration into the CNS in the context of enteroviral meningitis. As HIBCPP are permissive for infection with EV30, they constitute a valuable human in vitro model to study viral infection at the BCSFB.


Assuntos
Barreira Hematoencefálica/imunologia , Barreira Hematoencefálica/virologia , Quimiotaxia/imunologia , Enterovirus Humano B/imunologia , Papiloma do Plexo Corióideo/imunologia , Papiloma do Plexo Corióideo/virologia , Linfócitos T/imunologia , Barreira Hematoencefálica/metabolismo , Linhagem Celular , Quimiocinas/metabolismo , Humanos , Linfócitos T/metabolismo , Migração Transendotelial e Transepitelial/imunologia
2.
J Neurovirol ; 14(1): 78-84, 2008 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-18300078

RESUMO

The authors describe a patient with known human immunodeficiency virus (HIV)-1 infection who presented with two generalized seizures and was found to have extensive white matter disease and a left/bilateral temporo-occipital focal slowing on electroencephalography (EEG). There were no magnetic resonance imaging (MRI) or cerebrospinal fluid (CSF) indications for opportunistic infection. Plasma viremia was controlled, whereas viral replication was uncontrolled in CSF. CSF-specific genotype-guided adaptation of the antiretroviral therapy in order to optimize central nervous system (CNS) penetration resulted in clinical improvement and normalization of MRI and EEG. Our case report illustrates the importance of individualized antiretroviral therapy in HIV infected patients with neurological complications.


Assuntos
Complexo AIDS Demência/tratamento farmacológico , Fármacos Anti-HIV/uso terapêutico , Terapia Antirretroviral de Alta Atividade/métodos , HIV-1/fisiologia , Complexo AIDS Demência/líquido cefalorraquidiano , Complexo AIDS Demência/patologia , Complexo AIDS Demência/virologia , Adenina/administração & dosagem , Adenina/análogos & derivados , Adenina/farmacocinética , Adenina/uso terapêutico , Adulto , Alcinos , Fármacos Anti-HIV/administração & dosagem , Fármacos Anti-HIV/farmacocinética , Anticonvulsivantes/classificação , Anticonvulsivantes/uso terapêutico , Sulfato de Atazanavir , Benzoxazinas/administração & dosagem , Benzoxazinas/farmacocinética , Benzoxazinas/uso terapêutico , Líquido Cefalorraquidiano/virologia , Ciclopropanos , Didanosina/administração & dosagem , Didanosina/farmacocinética , Didanosina/uso terapêutico , HIV-1/genética , HIV-1/isolamento & purificação , Humanos , Indinavir/administração & dosagem , Indinavir/farmacocinética , Indinavir/uso terapêutico , Lamivudina/administração & dosagem , Lamivudina/farmacocinética , Lamivudina/uso terapêutico , Masculino , Nelfinavir/administração & dosagem , Nelfinavir/farmacocinética , Nelfinavir/uso terapêutico , Nevirapina/administração & dosagem , Nevirapina/farmacocinética , Nevirapina/uso terapêutico , Oligopeptídeos/administração & dosagem , Oligopeptídeos/farmacocinética , Oligopeptídeos/uso terapêutico , Organofosfonatos/administração & dosagem , Organofosfonatos/farmacocinética , Organofosfonatos/uso terapêutico , Piridinas/administração & dosagem , Piridinas/farmacocinética , Piridinas/uso terapêutico , Ritonavir/administração & dosagem , Ritonavir/farmacocinética , Ritonavir/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...